Further characterization revealed ovarian cancer, bile duct cholangiocarcinoma, lung adenocarcinoma, lung squamous cell carcinoma, and head and neck cell carcinoma to be positive for cancer-specific plectin (CSP) expression [8,9,10]. This evidence concerns the gene PLEC and ovarian cancer.